About 8 results found for searched term "CETP" (0.205 seconds)
| Cat.No. | Name | Target |
|---|---|---|
| M1829 | Torcetrapib | CETP |
| CP-529414 | ||
| Torcetrapib (CP-529414) is a prototype cholesteryl ester transfer protein (CETP) inhibitor with potential for decreasing atherosclerotic disease, increased cardiovascular events in clinical trials. | ||
| M2142 | Anacetrapib | CETP |
| MK-0859 | ||
| Anacetrapib is an orally active and potent inhibitor of CETP with IC50 of 7.9 nM and 11.8 nM for rhCETP and mutant CETP(C13S) respectively. | ||
| M2330 | Evacetrapib | CETP |
| LY2484595 | ||
| Evacetrapib (LY2484595) is a potent and selective inhibitor of CETP which inhibited human recombinant CETP protein (5.5 nM IC(50)) and CETP activity in human plasma (36 nM IC(50)) in vitro. | ||
| M3438 | Dalcetrapib | CETP |
| JTT-705, RO4607381 | ||
| Dalcetrapib (JTT-705) is a rhCETP inhibitor with IC50 of 0.2 μM that increases the plasma HDL cholesterol. | ||
| M6522 | BMS 795311 | Others |
| BMS 795311 is a potent cholesteryl ester transfer protein (CETP) inhibitor. | ||
| M8067 | CP 532623 | Others |
| CP-532623 is a potent inhbitor of cholesteryl ester transfer protein (CETP) that leads to elevated high-density lipoprotein cholesterol levels. | ||
| M8068 | CP 524515 | Others |
| CP-524515 is a potent inhbitor of cholesteryl ester transfer protein (CETP) that leads to elevated high-density lipoprotein cholesterol levels. | ||
| M40942 | Obicetrapib | CETP |
| DEZ-001; TA-8995 | ||
| Obicetrapib (DEZ-001) is a selective, orally active cholesterol transporter protein (CETP) inhibitor that blocks the function of CETP and significantly reduces LDL-C while significantly increasing HDL-C levels, and may be used in studies related to atherosclerosis and Alzheimer's disease (AD). | ||
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.
